-
Posted: November 24th, 2023, 3:00am GMT
Conditions: Laparoscopic Gastrectomy; Ropivacaine
Interventions: Drug: 0.5% Ropivacaine; Drug: Saline
Sponsors: SanQing Jin
Not yet recruiting
-
Posted: November 17th, 2023, 3:00am GMT
Conditions: Metastatic Colorectal Cancer
Interventions: Drug: Regorafenib (Stivarga, BAY73-4506)
Sponsors: Bayer
Not yet recruiting
-
Posted: November 13th, 2023, 3:00am GMT
Conditions: Colorectal Cancer; Gastrointestinal Dysfunction
Interventions: Device: Electroacupuncture group; Other: Sham EA group
Sponsors: Shanghai Yueyang Integrated Medicine Hospital; ShuGuang Hospital; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Baoshan hospital of Integrated Traditional Chinese and Western Medicine
Not yet recruiting
-
Posted: November 13th, 2023, 3:00am GMT
Conditions: HPV Infection
Interventions: Other: Urine Sample Collection; Other: Self-collected Vaginal Swab; Other: Blood Samples
Sponsors: International Vaccine Institute; London School of Hygiene and Tropical Medicine; Karolinska Institutet; Centers for Disease Control and Prevention
Not yet recruiting
-
Posted: November 2nd, 2023, 2:00am GMT
Conditions: Paralytic Ileus; Nausea; Defecation Disorder
Interventions: Procedure: Abdominal Exercise (digital rectal stimulation, abdominal massage)
Sponsors: Tepecik Training and Research Hospital
Completed
-
Posted: October 27th, 2023, 2:00am GMT
Conditions: Total Mesorectal Excision; Rectal Neoplasms; Robotic Surgical Procedures; Laparoscopy
Interventions: Procedure: Robotic-assisted total mesorectal excision; Procedure: laparoscopic-assisted total mesorectal excision
Sponsors: The First Hospital of Jilin University; Jilin Provincial Tumor Hospital; Daping Hospital and the Research Institute of Surgery of the Third Military Medical University; The Second Affiliated Hospital of Dalian Medical University; The Second Affiliated Hospital of Harbin Medical University
Not yet recruiting
-
Posted: October 25th, 2023, 2:00am GMT
Conditions: Colorectal Cancer
Interventions: Drug: Serplulimab + FOLFOXIRI; Radiation: Radiation therapy
Sponsors: Sun Yat-sen University
Not yet recruiting
-
Posted: October 24th, 2023, 2:00am GMT
Conditions: Thrombotic Microangiopathies
Sponsors: University Hospital, Strasbourg, France
Recruiting
-
Posted: October 4th, 2023, 2:00am GMT
Conditions: Rectum Cancer
Interventions: Procedure: Plastic surgery of the pelvic floor and perineal wound with counter-displaced skin-subcutaneous fascial flaps after extralevatory abdominal-perineal extirpation of the rectum; Procedure: Plastic surgery of the pelvic floor and perineal wound with local tissues; Procedure: Plastic surgery of the pelvic floor and perineal wound with mesh endoprosthesis
Sponsors: Kuban State Medical University; State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital; City Clinical Oncology Hospital No 1
Not yet recruiting
-
Posted: September 28th, 2023, 2:00am GMT
Conditions: Dyspareunia; Pelvic Pain; Sexual Dysfunction; Radiation Toxicity
Interventions: Behavioral: Pelvic health therapy; Device: Dilator feasability
Sponsors: Indiana University
Not yet recruiting
-
Posted: September 27th, 2023, 2:00am GMT
Conditions: Locally Advanced Rectal Cancer
Interventions: Drug: capecitabine; Drug: tislelizumab; Drug: thymalfasin; Radiation: long-term radiotherapy
Sponsors: Beijing Friendship Hospital; Peking Union Medical College Hospital
Not yet recruiting
-
Posted: September 27th, 2023, 2:00am GMT
Conditions: Morbid Obesity; Rectal Cancer; Surgical Outcomes
Interventions: Procedure: BIB positioning
Sponsors: Federico II University
Recruiting
-
Posted: September 25th, 2023, 2:00am GMT
Conditions: KSHV Inflammatory Cytokine Syndrome (KICS); Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
Interventions: Drug: Pacritinib
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: September 22nd, 2023, 2:00pm GMT
Conditions: Anal Squamous Cell Carcinoma
Interventions: Radiation: Radiotherapy - Low risk group; Radiation: Radiotherapy - Standard risk group; Radiation: Radiotherapy - Intermediate risk group; Radiation: Radiotherapy - High risk group
Sponsors: University Health Network, Toronto
Recruiting
-
Posted: September 21st, 2023, 2:00am GMT
Conditions: Lymph Node Metastasis; Cancer of Rectum and Anus; Oxaliplatin; Intestinal Neoplasms; Gastrointestinal Neoplasms; Rectal Diseases; Rectal Neoplasms
Interventions: Drug: Experimental: FOLFOXIRI and Lateral lymph node dissection; Drug: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Enrolling by invitation
-
Posted: September 21st, 2023, 2:00am GMT
Conditions: Chemotherapy Effect; Rectal Cancer
Interventions: Procedure: Radical total mesorectal excision; Other: Salavge Adjuvant Chemoradiotherapy
Sponsors: Sun Yat-sen University
Recruiting
-
Posted: September 18th, 2023, 2:00am GMT
Conditions: HPV InfectioN; HPV-Related Carcinoma
Interventions: Biological: Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell); Biological: placebo
Sponsors: Sinocelltech Ltd.; Guangxi Center for Disease Control and Prevention; Henan Center for Disease Control and Prevention; Sichuan Center for Disease Control and Prevention; Shanxi Center for Disease Control and Prevention; Yunnan Center for Disease Control and Prevention
Active, not recruiting
-
Posted: September 14th, 2023, 2:00am GMT
Conditions: Anastomotic Stenosis
Interventions: Procedure: Transanal and transabdominal combined endoscopic resection of rectal stenosis and anal reconstruction
Sponsors: Sun Yat-sen University
Recruiting
-
Posted: September 13th, 2023, 2:00pm GMT
Conditions: Rectal Cancer
Interventions: Drug: CapeOX + cetuximab; Drug: CapeOX + bevacizumab; Radiation: radiotherapy
Sponsors: Tang-Du Hospital
Not yet recruiting
-
Posted: September 13th, 2023, 2:00am GMT
Conditions: Fluorescence; Indocyanine Green; Rectal Cancer Surgery
Interventions: Device: Fluorescence laparoscopic system
Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
-
Posted: September 8th, 2023, 2:00am GMT
Conditions: Metastatic Colorectal Cancer
Interventions: Drug: Regorafenib (Stivarga, BAY73-4506)
Sponsors: Bayer
Completed
-
Posted: September 8th, 2023, 2:00am GMT
Conditions: Clostridium Difficile Infections
Sponsors: Fondation Hôpital Saint-Joseph
Recruiting
-
Posted: September 7th, 2023, 2:00am GMT
Conditions: Dehiscence Wound; Secondary Perineal Tear; Episiotomy; Dehiscence
Interventions: Other: Clinical examination and pictures; Other: Questionnaire
Sponsors: Herlev Hospital
Recruiting
-
Posted: September 6th, 2023, 2:00am GMT
Conditions: Colorectal Neoplasms
Interventions: Drug: Thymalfasin
Sponsors: Beijing Friendship Hospital
Not yet recruiting
-
Posted: August 24th, 2023, 2:00pm GMT
Condition: Perineal Pain
Intervention: Procedure: US assisted caudal epidural pulsed radiofrequency
Sponsor: Assiut University
Not yet recruiting
-
Posted: August 14th, 2023, 2:00am GMT
Conditions: Hemorrhoids; Anal Fissure and Fistula; Perianal Abscess; Perianal Fistula; Pilonidal Sinus; Perianal Skin Tags
Interventions: Other: Ultrasound guided Pudendal nerve block
Sponsors: Nepal Mediciti Hospital
Recruiting
-
Posted: August 8th, 2023, 2:00am GMT
Conditions: Locally Advanced Rectal Cancer
Interventions: Drug: AK104; Drug: Capecitabine; Radiation: Neoadjuvant Radiotherapy
Sponsors: Sun Yat-sen University; Akeso; Haplox Biotechnology Co., Ltd.
Recruiting
-
Posted: August 3rd, 2023, 2:00am GMT
Conditions: Head and Neck Cancer; Cervical Cancer; Non-small Cell Carcinoma; Melanoma; Ovarian Cancer; Anogenital Cancers; HPV - Anogenital Human Papilloma Virus Infection; HPV-Related Cervical Carcinoma; HPV-Related Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV-Related Malignancy; HPV-Related Adenocarcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Associated Vaginal Adenocarcinoma; HPV-Related Endocervical Adenocarcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Verrucous Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV Positive Rectal Squamous Cell Carcinoma
Interventions: Biological: TSC-204-A0201; Biological: TSC-204-C0702; Biological: TSC-200-A0201; Biological: TSC-204-A0201 + TSC-204-C0702; Biological: TSC-204-A0201 + TSC-200-A0201; Biological: TSC-204-C0702 + TSC-200-A0201; Biological: TSC-204-A0201 + TSC-203-A0201; Biological: TSC-204-C0702 + TSC-203-A0201; Biological: TSC-200-A0201 + TSC-203-A0201
Sponsors: TScan Therapeutics, Inc.
Recruiting
-
Posted: August 1st, 2023, 2:00pm GMT
Conditions: Advanced Malignant Solid Neoplasm; Anal Carcinoma; Biliary Tract Carcinoma; Bladder Carcinoma; Breast Carcinoma; Carcinoid Tumor; Cervical Carcinoma; Colorectal Carcinoma; Gastric Carcinoma; Glioblastoma; Head and Neck Carcinoma; HER2-Positive Breast Carcinoma; Lung Carcinoma; Lung Small Cell Carcinoma; Malignant Germ Cell Tumor; Neuroendocrine Carcinoma; Ovarian Carcinoma; Pancreatic Carcinoma; Prostate Small Cell Neuroendocrine Carcinoma; Prostate Carcinoma
Interventions: Procedure: Clinical Encounter; Other: Home Health Encounter; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: Mayo Clinic
Recruiting
-
Posted: August 1st, 2023, 2:00am GMT
Conditions: Genital Psoriasis; Scalp Psoriasis
Interventions: Drug: Risankizumab; Drug: Placebo for Risankizumab
Sponsors: AbbVie
Recruiting
-
Posted: July 28th, 2023, 2:00pm GMT
Condition: Rectal Cancer
Intervention: Procedure: Surgery
Sponsor: National Taiwan University Hospital
Recruiting
-
Posted: July 25th, 2023, 2:00pm GMT
Conditions: Cervical Cancer; Anal Cancer; Penile Cancer
Interventions: Behavioral: Personalized Chatbot Intervention; Behavioral: Non-Personalized Chatbot Intervention; Behavioral: No Chatbot Control
Sponsor: University of Maryland, College Park
Recruiting
-
Posted: July 19th, 2023, 2:00pm GMT
Conditions: Cervical Cancer; Head and Neck Squamous Cell Carcinoma; Carcinoma of Vagina; Carcinoma of Penis; Anal Cancer; Carcinoma of Vulva
Interventions: Biological: HRYZ-T101 Injection; Drug: Fludarabine + Cyclophosphamide
Sponsor: SYZ Cell Therapy Co..
Not yet recruiting
-
Posted: July 13th, 2023, 2:00pm GMT
Conditions: Rectal Neoplasms; Low Anterior Resection Syndrome; Anastomotic Leak; Quality of Life
Interventions: Procedure: Parks technique; Procedure: Bacon technique
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Not yet recruiting
-
Posted: July 12th, 2023, 2:00pm GMT
Conditions: Advanced Solid Tumors
Interventions: Drug: LCB84; Drug: Anti-PD-1 monoclonal antibody
Sponsors: LegoChem Biosciences, Inc; AntibodyChem Biosciences, Inc.
Recruiting
-
Posted: July 11th, 2023, 2:00pm GMT
Conditions: Anal Cancer
Interventions: Other: Biopsies
Sponsors: Sahlgrenska University Hospital, Sweden; Göteborg University
Not yet recruiting
-
Posted: July 11th, 2023, 2:00pm GMT
Condition: Rectal Cancer
Interventions: Radiation: Radiation; Drug: Chemotherapy; Procedure: Surgery
Sponsor: Osaka University
Recruiting
-
Posted: June 27th, 2023, 2:00pm GMT
Conditions: Low Anterior Resection Syndrome
Interventions: Procedure: Transanal irrigation; Combination Product: Best supportive care
Sponsors: National Cancer Institute, Lithuania
Recruiting
-
Posted: June 14th, 2023, 2:00pm GMT
Condition: Anal Cancer
Interventions: Radiation: Radiation (reduced elective nodal dose (30.6 Gy); Drug: Capecitabine; Drug: Mitomycin c
Sponsor: University of Cincinnati
Recruiting
-
Posted: June 5th, 2023, 2:00am GMT
Conditions: Hidradenitis Suppurativa
Interventions: Drug: Upadacitinib; Drug: Placebo
Sponsors: AbbVie
Recruiting
-
Posted: May 24th, 2023, 2:00pm GMT
Conditions: Rectal Cancer; Lymph Node Cancer Metastatic
Intervention: Procedure: ICG-guided lymphadenectomy
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
-
Posted: May 15th, 2023, 2:00pm GMT
Conditions: Anal Intraepithelial Neoplasia; Anal High-grade Squamous Intraepithelial Lesion; Anal HSIL
Intervention: Diagnostic Test: Physical examination
Sponsors: David Finch; Lancashire Teaching Hospitals NHS Foundation Trust
Not yet recruiting
-
Posted: May 15th, 2023, 2:00pm GMT
Conditions: Melanoma; Non Small Cell Lung Cancer; Head and Neck Squamous Cell Carcinoma; High Grade Serous Adenocarcinoma of Ovary; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Endometrial Cancer; Cervical Cancer; Renal Cell Carcinoma; Bladder Cancer; Esophageal Cancer; Gastric Cancer; Gastroesophageal-junction Cancer; Colorectal Cancer; Anal Cancer; Hepatocellular Carcinoma; Bile Duct Cancer
Interventions: Drug: AI-061
Sponsors: OncoC4, Inc.; OncoC4 AU Pty Ltd; Avance Clinical
Recruiting
-
Posted: May 5th, 2023, 2:00pm GMT
Condition: Locally Advanced Rectal Cancer
Interventions: Combination Product: Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor); Combination Product: Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
Sponsor: Beijing Friendship Hospital
Recruiting
-
Posted: May 3rd, 2023, 2:00am GMT
Conditions: Metastatic Colorectal Cancer (mCRC)
Interventions: Drug: Regorafenib (BAY73-4506, Stivarga®); Drug: TAS-102 (trifluridine and tipiracil, Lonsurf®); Drug: Bevacizumab
Sponsors: Bayer
Active, not recruiting
-
Posted: May 1st, 2023, 2:00pm GMT
Condition: Anal Squamous Cell Carcinoma
Interventions: Radiation: Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery; Drug: Mitomycin-C; Drug: 5-Fluorouracil; Drug: Capecitabine
Sponsors: Columbia University; Varian Medical Systems
Recruiting
-
Posted: April 28th, 2023, 2:00pm GMT
Conditions: Anal Cancer; Human Papilloma Virus; Anal Intraepithelial Neoplasia; Genital Neoplasm; Genital Cancer
Intervention: Other: Dual Pathology
Sponsor: Imperial College London
Recruiting
-
Posted: April 28th, 2023, 2:00pm GMT
Conditions: Anal Cancer; Anal Squamous Intraepithelial Neoplasia
Intervention:
Sponsor: Imperial College London
Recruiting
-
Posted: April 27th, 2023, 2:00pm GMT
Condition: Anorectal Cancer
Intervention: Radiation: IMRT
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Not yet recruiting
-
Posted: April 24th, 2023, 2:00am GMT
Conditions: Colorectal Surgery; Colorectal Cancer; Rectal/Anal
Interventions: Device: COLO BT™; Other: Stoma Creation
Sponsors: JSR Medical Co., Ltd.
Recruiting
-
Posted: April 18th, 2023, 2:00pm GMT
Condition: Education, Medical
Intervention: Behavioral: Enhanced Training on screening and treatment of HSIL (e-STH)
Sponsors: University of Maryland, Baltimore; National Cancer Institute (NCI)
Recruiting
-
Posted: March 28th, 2023, 2:00pm GMT
Conditions: Cervical Cancer; Head and Neck Squamous Cell Carcinoma; Oropharyngeal Cancer; Vagina Tumor; Carcinoma of Penis; Anal Carcinoma; Carcinoma of Vulva
Interventions: Drug: Fludarabine + Cyclophosphamide; Biological: HRYZ-T101 TCR-T Cell
Sponsors: HRYZ Biotech Co.
Recruiting
-
Posted: February 23rd, 2023, 3:00pm GMT
Condition: Colorectal Cancer
Intervention: Procedure: Natural Orifice Specimen Extraction
Sponsor: Chang Gung Memorial Hospital
Not yet recruiting
-
Posted: January 18th, 2023, 3:00am GMT
Conditions: Fanconi Anemia; Inherited Bone Marrow Failure Syndrome
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: January 17th, 2023, 3:00pm GMT
Conditions: Cervical Cancer; Throat Cancer; Oropharynx Cancer; Anal Cancer; Vulva Cancer; Vaginal Cancer; Penile Cancer; Metastatic Cancer; HPV-Related Malignancy; HPV-Related Carcinoma; HPV-Related Cervical Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV-Related Adenocarcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Associated Vaginal Adenocarcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Related Endocervical Adenocarcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV Positive Rectal Squamous Cell Carcinoma
Interventions: Biological: E7 TCR-T cells
Sponsors: Christian Hinrichs
Recruiting
-
Posted: January 12th, 2023, 3:00am GMT
Conditions: Low Anterior Resection Syndrome
Interventions: Other: Paula Method of muscle exercises
Sponsors: Hadassah Medical Organization
Recruiting
-
Posted: December 28th, 2022, 3:00pm GMT
Conditions: Rectal Cancer; Robotic; Anastomotic Leak; Laparoscopic
Interventions: Device: Surform
Sponsors: Nanchang University
Recruiting
-
Posted: December 23rd, 2022, 3:00pm GMT
Conditions: Anal Carcinoma; Hematopoietic and Lymphoid Cell Neoplasm; HIV Infection; Kaposi Sarcoma; Lymphoma; Malignant Solid Neoplasm; Multicentric Castleman Disease; Plasmablastic Lymphoma; Recurrent Kaposi Sarcoma; Recurrent Lymphoma; Recurrent Plasmablastic Lymphoma; Transplant-Related Kaposi Sarcoma
Interventions: Procedure: Biospecimen Collection
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI)
Recruiting
-
Posted: December 9th, 2022, 3:00pm GMT
Conditions: Benign Colorectal Neoplasm; Non-Neoplastic Anal Disorder
Interventions: Dietary Supplement: Dietary Fiber; Procedure: Proctoscopy or anoscopy with Biopsy; Other: Questionnaire Administration
Sponsor: OHSU Knight Cancer Institute
Recruiting
-
Posted: December 8th, 2022, 3:00am GMT
Conditions: Adult Patients; Intestinal Continuity (Anastomosis); Colon Cancer
Interventions: Procedure: Any kind of colectomy
Sponsors: Hospital San Carlos, Madrid; Spanish Association of Surgeons (AEC); Hospital Universitario La Fe; Complejo Hospitalario Universitario de Vigo
Enrolling by invitation
-
Posted: December 7th, 2022, 3:00am GMT
Conditions: HPV-Associated Cervical Carcinoma; HPV-Related Carcinoma; HPV-Related Malignancy; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Related Adenocarcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV-Related Endocervical Adenocarcinoma; Cervical Cancer; Oropharynx Cancer; Anal Cancer; Vulvar Cancer; Penile Cancer; Vaginal Cancer
Interventions: Drug: Conditioning, E7 TCR-T cells, and aldesleukin
Sponsors: Christian Hinrichs; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: October 20th, 2022, 2:00pm GMT
Conditions: Human Papillomavirus Infection; HPV; HPV Infection; Anal Cancer; Cancer; Men; HPV 16 Infection
Intervention:
Sponsors: Monash University; The Alfred; University of Melbourne
Recruiting
-
Posted: October 20th, 2022, 2:00pm GMT
Conditions: Human Papillomavirus Infection; HPV; HPV Infection; Anal Cancer; Cancer; Men; HPV 16 Infection
Intervention:
Sponsors: Monash University; The Alfred; University of Melbourne
Recruiting
-
Posted: September 27th, 2022, 2:00pm GMT
Conditions: Malignant Female Reproductive System Neoplasm
Interventions: Procedure: Biospecimen Collection; Other: Interview
Sponsors: Fred Hutchinson Cancer Center; National Cancer Institute (NCI); US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet); Instituto Dermatológico Dominicano y Cirugía de Piel (IDCP)
Recruiting
-
Posted: September 8th, 2022, 2:00am GMT
Conditions: Anal High-grade Squamous Intraepithelial Lesion
Interventions: Procedure: OPTIMIZATION PHASE
Sponsors: Institute of HIV Research and Innovation Foundation, Thailand; National Institutes of Health (NIH); amfAR, The Foundation for AIDS Research
Recruiting
-
Posted: August 22nd, 2022, 2:00pm GMT
Conditions: HIV-Associated Malignant Neoplasm; HIV Infections; Cancer; AIDS Related Lymphoma; AIDS-related Kaposi Sarcoma; AIDS-Related Malignancy; Anal Cancer; HPV-Related Malignancy
Interventions: Other: Non-Interventional; Other: Non-Interventional Follow-up
Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI)
Recruiting
-
Posted: August 16th, 2022, 2:00am GMT
Conditions: Rectal Cancer; Anastomotic Leak
Interventions: Device: removal of transanal drainage tube
Sponsors: Qilu Hospital of Shandong University
Recruiting
-
Posted: August 1st, 2022, 2:00am GMT
Conditions: Postoperative Cognitive Dysfunction
Interventions: Other: Transcutaneous acupoint electrical stimulation
Sponsors: Subei People's Hospital of Jiangsu Province
Not yet recruiting
-
Posted: July 18th, 2022, 2:00pm GMT
Conditions: Pleural Effusion, Malignant; Ascites, Malignant; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Renal; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Neuroendocrine; Carcinoma, Thymic; Carcinoma, Pancreatic; Carcinoma Breast; Carcinoma, Ovarian; Carcinoma Bladder; Carcinoma of Unknown Primary; Carcinoma of the Head and Neck; Carcinoma of the Oropharynx; Carcinoma of the Larynx; Carcinoma of the Bladder; Carcinoma of Esophagus; Carcinoma of the Nasopharynx; Carcinoma of the Penis; Carcinoma of the Cervix; Carcinoma of the Anus; Carcinoma of the Vulva; Carcinoma of the Appendix; Carcinoma of the Oral Cavity; Cholangiocarcinoma; Melanoma; Mesothelioma; Pancreatic Cancer
Intervention:
Sponsors: Travera Inc; xCures
Recruiting
-
Posted: June 30th, 2022, 2:00pm GMT
Conditions: Anal Cancer; Anal Carcinoma; Anal Squamous Cell Carcinoma
Interventions: Radiation: online adaptive radiotherapy
Sponsors: Herlev Hospital
Recruiting
-
Posted: June 21st, 2022, 2:00am GMT
Conditions: Colorectal Cancer; Diagnoses Disease; Polyp of Colon; Adenoma Colon
Interventions: Diagnostic Test: Diagnostic high-definition white-light (HDWL) colonoscopy
Sponsors: Institute of Gastroenterology and Advance Endoscopy; Austral University, Argentina; Hospital Nacional Profesor Alejandro Posadas
Completed
-
Posted: May 3rd, 2022, 2:00pm GMT
Conditions: Adult Solid Tumor
Interventions: Biological: SQZ-eAPC-HPV; Biological: Pembrolizumab
Sponsors: SQZ Biotechnologies
Active, not recruiting
-
Posted: April 21st, 2022, 2:00am GMT
Conditions: Rectal Cancer
Interventions: Radiation: Magnetic resonance guided radiotherapy; Drug: Chemotherapy
Sponsors: Sun Yat-sen University
Enrolling by invitation
-
Posted: April 19th, 2022, 2:00pm GMT
Conditions: High-Grade Anal Intraepithelial Neoplasia
Interventions: Drug: Lopinavir / Ritonavir
Sponsors: University of Wisconsin, Madison; Wisconsin Partnership Program
Recruiting
-
Posted: April 19th, 2022, 2:00pm GMT
Conditions: Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III); Human Papillomavirus (HPV) Infections; High-risk HPV; HPV-16/ 18
Intervention: Biological: Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
Sponsors: Miquel Angel Pavon Ribas; Hospital del Mar; Catalan Institute of Health
Recruiting
-
Posted: April 6th, 2022, 2:00am GMT
Conditions: CNS Cancer; Head and Neck Cancer; GI Cancer; Gynecologic Cancer; Prostate Cancer; Thoracic Cancer; Breast Cancer
Interventions: Radiation: Pencil Beam Scanning Proton Therapy
Sponsors: The New York Proton Center
Recruiting
-
Posted: March 2nd, 2022, 3:00am GMT
Conditions: Breast Fibrosis; Breast Cancer; Breast Cancer Female; Breast Neoplasms; Breast Carcinoma in Situ; Breast Carcinoma
Interventions: Other: no intervention
Sponsors: Erasmus Medical Center; Stichting BeterKeten, the Netherlands; Albert Schweitzer hospital, Dordrecht, the Netherlands; Franciscus Gasthuis and Vlietland Hospital, Rotterdam and Schiedam, the Netherlands; Maasstad hospital, Rotterdam, the Netherlands
Enrolling by invitation
-
Posted: February 21st, 2022, 3:00am GMT
Conditions: Cervical Cancer; Human Papilloma Virus; Human Immunodeficiency Virus; HPV-Related Carcinoma
Interventions: Procedure: Blood collection; Procedure: Oral, cervicovaginal and anal specimen collection; Procedure: Anoscopy & Biopsy of Acetowhite Lesions; Procedure: Colposcopy & Biopsy of Acetowhite Lesions; Procedure: Ablative Treatment; Procedure: LEEP (Loop Electrosurgical Excision Procedure)
Sponsors: Montefiore Medical Center; National Cancer Institute (NCI); Rwanda Military Hospital; University of Rwanda
Recruiting
-
Posted: February 18th, 2022, 3:00pm GMT
Conditions: Rectum Cancer; Stoma Colostomy; Faecal Incontinence; Leakage, Anastomotic
Intervention:
Sponsor: Shanghai 10th People's Hospital
Recruiting
-
Posted: February 17th, 2022, 3:00am GMT
Conditions: Abdominal Wound Dehiscence; Necrotizing Soft Tissue Infection; Lower Extremity Wound; Pilonidal Sinus; Anal Fistula; Hidradenitis Suppurativa; Pressure Injury
Interventions: Device: Myriad Matrix™ and Myriad Morcells™
Sponsors: Aroa Biosurgery Limited
Recruiting
-
Posted: February 14th, 2022, 3:00am GMT
Conditions: Cervical Carcinoma; Human Papillomavirus Infection
Interventions: Biological: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Bivalent Vaccine; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: February 1st, 2022, 3:00pm GMT
Conditions: HPV-related Lower Genital Tract Neoplasias; HPV-related Anal Neoplasias; Early Stage Lower Genital Tract Cancers
Interventions: Diagnostic Test: Diagnostic tests for anal cancer screening
Sponsors: Icahn School of Medicine at Mount Sinai; M.D. Anderson Cancer Center; Medical University of South Carolina
Recruiting
-
Posted: November 22nd, 2021, 3:00pm GMT
Conditions: Anal Squamous Cell Carcinoma; Stage 0 Anal Cancer AJCC v8; Stage I Anal Cancer AJCC v8; Stage II Anal Cancer AJCC v8; Stage IIA Anal Cancer AJCC v8; Stage IIB Anal Cancer AJCC v8; Stage III Anal Cancer AJCC v8; Stage IIIA Anal Cancer AJCC v8; Stage IIIB Anal Cancer AJCC v8; Stage IIIC Anal Cancer AJCC v8
Interventions: Procedure: Computed Tomography; Other: Electronic Health Record Review; Procedure: Follow-Up; Procedure: Positron Emission Tomography
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Active, not recruiting
-
Posted: November 8th, 2021, 3:00am GMT
Conditions: Anal Melanoma; Bladder Melanoma; Cervical Melanoma; Esophageal Melanoma; Gallbladder Melanoma; Mucosal Melanoma; Mucosal Melanoma of the Head and Neck; Mucosal Melanoma of the Urinary System; Oral Cavity Mucosal Melanoma; Penile Mucosal Melanoma; Rectal Melanoma; Recurrent Mucosal Melanoma; Sinonasal Mucosal Melanoma; Stage II Vulvar Cancer AJCC v8; Stage III Vulvar Cancer AJCC v8; Stage IV Vulvar Cancer AJCC v8; Urethral Melanoma; Vaginal Melanoma; Vulvar Melanoma
Interventions: Drug: Cabozantinib S-malate; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Biological: Nivolumab; Drug: Placebo Administration; Procedure: Positron Emission Tomography
Sponsors: National Cancer Institute (NCI)
Suspended
-
Posted: October 12th, 2021, 2:00pm GMT
Conditions: AIDS-Related Anal Carcinoma; AIDS-Related Cervical Carcinoma; High Grade Anal Intraepithelial Neoplasia; High Grade Cervical Intraepithelial Neoplasia; HIV Infection
Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection - Anal; Procedure: Biospecimen Collection - Cervical; Procedure: Colposcopy; Procedure: High Resolution Anoscopy; Procedure: Imaging Technique
Sponsors: University of California, San Francisco; National Cancer Institute (NCI); US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
Recruiting
-
Posted: September 10th, 2021, 2:00pm GMT
Condition: Anal Canal Cancer
Intervention: Radiation: chemo-radiation treatment
Sponsor: AHS Cancer Control Alberta
Recruiting
-
Posted: August 30th, 2021, 2:00am GMT
Conditions: Human Papillomavirus
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
-
Posted: August 5th, 2021, 2:00am GMT
Conditions: Low Anterior Resection Syndrome (LARS>20); Refractory Medical Treatment After Rectal Resection
Interventions: Drug: BOTOX-A
Sponsors: University Hospital, Bordeaux
Terminated
-
Posted: August 2nd, 2021, 2:00pm GMT
Conditions: Stage III Breast Cancer; Stage IV Breast Cancer; Stage III Lung Cancer; Stage IV Lung Cancer; AML; Multiple Myeloma in Relapse; Carcinoma; Carcinoma, Pancreatic; Carcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma Breast; Carcinoma Prostate; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Neuroendocrine; Carcinoma, Small Cell Lung; Carcinoma, Ovarian; Carcinoma Bladder; Carcinoma of Esophagus; Carcinoma Cervix; Carcinoma, Thymic; Carcinoma, Ductal; Carcinoma of the Head and Neck; Carcinoma of the Lip; Carcinoma of the Oral Cavity; Carcinoma of Unknown Primary; Carcinoma of the Skin; Carcinoma of the Anus; Carcinoma of the Larynx; Carcinoma of the Penis; Carcinoma of the Oropharynx; Carcinoma of the Appendix; Carcinoma of the Paranasal Sinus; Carcinoma of the Vulva; Malignant Pleural Effusion; Malignant Ascites; Mesothelioma; Cholangiocarcinoma
Intervention:
Sponsor: Travera Inc
Not yet recruiting
-
Posted: July 29th, 2021, 2:00am GMT
Conditions: HPV Infection; Hiv; HPV Vaccine
Interventions: Biological: Gardasil ® 9
Sponsors: Columbia University
Active, not recruiting
-
Posted: June 18th, 2021, 2:00pm GMT
Conditions: AIDS-Related Anal Carcinoma; Anal Basaloid Squamous Cell Carcinoma; Anal Canal Cloacogenic Carcinoma; Anal Margin Squamous Cell Carcinoma; Anal Squamous Cell Carcinoma; HIV Infection; Rectal Squamous Cell Carcinoma; Stage I Anal Cancer AJCC v8; Stage II Anal Cancer AJCC v8; Stage II Rectal Cancer AJCC v8; Stage III Anal Cancer AJCC v8; Stage III Rectal Cancer AJCC v8
Interventions: Drug: Capecitabine; Drug: Fluorouracil; Radiation: Intensity-Modulated Radiation Therapy; Drug: Mitomycin; Biological: Nivolumab
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: June 1st, 2021, 2:00pm GMT
Conditions: Cancer Pain; Visceral Pain; Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Small Intestine Cancer; Pancreas Cancer; Liver Cancer; Colon Cancer; Biliary Tract Cancer; Stomach Cancer; Rectum Cancer; Peritoneal Cancer; Gastrointestinal Cancer Metastatic; Gastrointestinal Cancers - Anus; Gastrointestinal Cancers - Stomach; Gastrointestinal Cancers - Colorectal; Gastrointestinal Cancers - Small Intestine; Small Intestine Cancer Stage III; Small Intestine Cancer Stage IV; Small Intestine Cancer, Recurrent; Pancreas Cancer, Stage III; Pancreas Cancer, Stage IV; Pancreas Cancer, Metastatic; Pancreas Cancer, Recurrent; Liver Cancer Stage IIIa; Liver Cancer Stage IIIb; Liver Cancer Stage IIIc; Liver Cancer Stage IV; Colon Cancer Stage III; Colon Cancer Stage IV; Stomach Cancer Stage III; Stomach Cancer Stage IV; Stomach Cancer Recurrent; Rectum Cancer, Recurrent; Gastrointestinal Cancers - Liver; Anal Cancer; Anal Cancer Stage III; Anal Cancer Stage IV; Anal Cancer Recurrent; Anal Cancer Metastatic; Anal Cancer, Stage IIIA; Anal Cancer, Stage IIIB; Appendix Cancer; Ampullary Cancer; Bile Duct Cancer; Bile Duct Cancer Stage III; Bile Duct Cancer Stage IV; Bile Duct Cancer Stage IVA; Bile Duct Cancer Stage IVB; Bile Duct Cancer Recurrent; Carcinoid Tumor; Carcinoid Tumor of Pancreas; Carcinoid Tumor of Large Intestine; Carcinoid Tumor of GI System; Carcinoid Tumor of Colon; Carcinoid Tumor of Liver; Carcinoid Tumor of Cecum; Carcinoid Tumor of Ileum; Carcinoid Tumor of Rectum; Carcinoid Tumor of the Small Bowel; Carcinoid Tumor of the Stomach; Large Intestine Cancer; Esophagus Cancer; Esophagus Cancer, Stage III; Esophagus Cancer, Stage IV; Esophagus Cancer, Recurrent; Gallbladder Cancer; Gallbladder Cancer Stage III; Gallbladder Cancer Stage IV; Gastric (Stomach) Cancer; Neuroendocrine Tumor; Peritoneum Cancer; Rectal Cancer; Esophagus Cancer, Stage I; Esophagus Cancer, Stage II; Gallbladder Cancer Stage I; Gallbladder Cancer Stage II; Bile Duct Cancer Stage I; Bile Duct Cancer Stage II
Intervention: Device: PICO G2 4k
Sponsors: Cedars-Sinai Medical Center; National Cancer Institute (NCI)
Recruiting
-
Posted: May 28th, 2021, 2:00am GMT
Conditions: Tislelizumab; Locally Advanced Rectal Cancer; Total Neoadjuvant Treatment; PD-1
Interventions: Drug: Sintilimab
Sponsors: The First Hospital of Jilin University
Active, not recruiting
-
Posted: May 26th, 2021, 2:00pm GMT
Conditions: Viral Associated Malignancies; Kaposi Sarcoma; EBV/KSHV-associated Lymphomas
Interventions: Drug: Pomalidomide; Drug: Nivolumab
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: May 20th, 2021, 2:00pm GMT
Conditions: Squamous Cell Anal Carcinoma; Metastatic Squamous Cell Carcinoma
Intervention: Biological: Sample collection
Sponsors: Centre Hospitalier Universitaire de Besancon; National Cancer Institute, France; Novartis
Recruiting
-
Posted: May 19th, 2021, 2:00pm GMT
Conditions: Adult Solid Tumor
Interventions: Biological: SQZ-AAC-HPV; Drug: Ipilimumab; Drug: Nivolumab
Sponsors: SQZ Biotechnologies
Active, not recruiting
-
Posted: April 23rd, 2021, 2:00pm GMT
Conditions: Cervical Cancer; Anal Cancer; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Cervical Carcinoma; HPV-Related Carcinoma; Uterine Cervical Cancer
Interventions: Radiation: Radiation Treatment With or Without Chemotherapy; Other: Blood Sample Collection; Diagnostic Test: HPV Genotyping (HPV DNA Test); Diagnostic Test: Testing Archival Tumor Tissue; Other: Physical Exam; Diagnostic Test: Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan)
Sponsor: University of Chicago
Recruiting
-
Posted: March 17th, 2021, 2:00pm GMT
Conditions: MSI-H Colorectal Cancer; Melanoma; Anal Carcinoma; Mesothelioma; Triple Negative Breast Cancer; Lung Adenocarcinoma; Cholangiocarcinoma; Cervical Carcinoma; Kidney Clear Cell Carcinoma; Stomach Adenocarcinoma; Esophageal Adenocarcinoma; Uterine Adenocarcinoma; Head and Neck Squamous Cell Carcinoma; Sarcoma; Lung Squamous Cell Carcinoma; Urothelial Carcinoma; Thyroid Carcinoma; Hepatocellular Carcinoma; Uveal Melanoma; HER2-positive Breast Cancer; Pancreatic Adenocarcinoma; Squamous Esophageal Carcinoma; Epithelial Ovarian Cancer; Uterine Carcinosarcoma; Small Cell Lung Cancer; Hormone Receptor Positive / HER2-negative Breast Cancer; Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation; Colorectal Adenocarcinoma; Prostate Adenocarcinoma; Carcinoma of Unknown Primary; Other Histology
Interventions: Drug: Spartalizumab; Drug: Tislelizumab
Sponsors: SOLTI Breast Cancer Research Group; Novartis
Recruiting
-
Posted: January 25th, 2021, 3:00am GMT
Conditions: Ulcerative Colitis; Inflammatory Bowel Diseases; Ileal Pouch
Interventions: Procedure: ta-IPAA; Procedure: tabd-IPAA
Sponsors: Mount Sinai Hospital, Canada; Cedars-Sinai Medical Center; St Mary's Hospital, London; Universitaire Ziekenhuizen KU Leuven
Recruiting
-
Posted: January 22nd, 2021, 3:00pm GMT
Condition: Squamous Cell Carcinoma of the Anus Stage III
Interventions: Biological: Blood sample collection; Procedure: Biopsy
Sponsors: Centre Hospitalier Universitaire de Besancon; Boehringer Ingelheim
Recruiting